Mednet Logo
Community

Would involved site radiation therapy be recommended in a patient with POEMS syndrome whose myelopathy symptoms worsened after one cycle of CyBorD?

If radiation therapy is offered, what dose and fractionation would you use? Would there be any benefit or risk of concurrent rituximab?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University Hospital Basel
Answered on · Updated on

I would swiftly treat this patient with a common schedule, for instance, 5 x 4 Gy.

I do not see any risk of concurrent rituximab.

Join for free or sign in to see the full answer